Antonio Florita

Also affiliated with Novartis (Switzerland), Royal Marsden NHS Foundation Trust, Regeneron (United States), Leo Pharma (Australia), Sanofi (France), Novartis (Netherlands), Merck Serono S.A. (Switzerland), Amgen (Germany), Almirall (Spain), Rheinmetall (Czechia), Sanofi (Mexico), Fondazione IRCCS Istituto Nazionale dei Tumori, Merck Serono S.p.A. (Italy)

Health ProfessionsMedicineBiochemistry, Genetics and Molecular BiologySocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram”.

Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram

Journal of Clinical Oncology(2020)10.1200/jco.19.01902

N/A

0DataRank · unranked

73 citations

Rosalba Miceli, Hanna Eriksson, Julia Newton‐Bishop, Jérémie Nsengimana, May Chan +43 more